![Robert M. Murphy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert M. Murphy
Career history of Robert M. Murphy
Former positions of Robert M. Murphy
Companies | Position | Start | End |
---|---|---|---|
LAB International, Inc.
![]() LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Director/Board Member | - | 13/07/2007 |
Corporate Officer/Principal | - | 13/07/2007 | |
President | - | 13/07/2007 |
Statistics
International
Canada | 2 |
Operational
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
LAB International, Inc.
![]() LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Health Technology |
- Stock Market
- Insiders
- Robert M. Murphy
- Experience